Vericiguat prevents hepatic inflammation and microcirculatory dysfunction in the early phase of sepsis in mice. // Microvascular Research. – URL: https://www.sciencedirect.com/science/article/pii/S0026286226001305?dgcid=rss_sd_all
Vericiguat prevents hepatic inflammation and microcirculatory dysfunction in the early phase of sepsis in mice. Microvascular Research. https://www.sciencedirect.com/science/article/pii/S0026286226001305?dgcid=rss_sd_all
“Vericiguat prevents hepatic inflammation and microcirculatory dysfunction in the early phase of sepsis in mice.” Microvascular Research.
@article{article5298,
title = {Vericiguat prevents hepatic inflammation and microcirculatory dysfunction in the early phase of sepsis in mice},
journal = {Microvascular Research},
url = {https://www.sciencedirect.com/science/article/pii/S0026286226001305?dgcid=rss_sd_all}
}